Document is current
Any future updates will be listed below
-
Authors
Sakamoto, Takashi
Nishigori, Tatsuto
Goto, Rei
Kawakami, Koji
Nakayama, Takeo
Tsunoda, Shigeru
Hisamori, Shigeo
Hida, Koya
Obama, Kazutaka
- License Information
-
More Information
Article History
Received: 3 July 2024
Accepted: 16 September 2024
First Online: 30 September 2024
Declarations
:
: The study protocol was approved by the ethics committee of Kyoto University and the Ministry of Health, Labor, and Welfare (MHLW) advisory committee, which is composed of representatives of insurers and providers, academics, and journalists.
: KK received research funds from AstraZeneca, Eisai Co., Ltd., Kyowa Kirin Co., Ltd., OMRON Corporation, and Toppan Inc.; consulting fees from Advanced Medical Care Inc., JMDC Inc., Shin Nippon Biomedical Laboratories Ltd., and Ubicom Holdings Inc.; executive compensation from Cancer Intelligence Care Systems, Inc.; and honoraria from Kyoto University Original Co., Ltd., Pharma Business Academy, and Shionogi & Co., Ltd. The other authors declare that they have no conflicts of interest.
